Details of the Drug Reposition

General Information of This Drug (ID: DMCFGD4)

Drug Name
TM38837   DMCFGD4
Synonyms
TM-38837; compound 8; CHEMBL3341897; 1253641-65-4; TM38837; GTPL8705; SCHEMBL16127787; BCP24151; BDBM50044129; AKOS030525391; 1-(2,4-dichlorophenyl)-4-ethyl-N-piperidin-1-yl-5-[5-[2-[4-(trifluoromethyl)phenyl]ethynyl]thiophen-2-yl]pyrazole-3-carboxamide; 1-(2,4-Dichlorophenyl)-4-ethyl-N-(piperidin-1-yl)-5-(5-((4-(trifluoromethyl)phenyl)ethynyl)thiophen-2-yl)-1H-pyrazole-3-carboxamide
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Obesity DIS47Y1K 5B81 Phase 1 [1]
Metabolic disorder DIS71G5H 5C50-5D2Z Phase 1 [1]
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 8705).